NEW YORK (GenomeWeb) – NGX Bio said today that it has raised $3 million, which it will use to further develop its business brokering deals between customers seeking next-generation sequencing and the facilities that provide it.
The funding round was led by 180 Degree Capital, and included Third Kind Venture Capital, Lateral Capital, the Band of Angels, and the Berkeley Angel Network, among others.
NGX was founded in 2014. It provides global online access to NGS services for both human and non-human samples, matching the sequencing needs of customers with providers who have available sequencing capacity.
In a statement, the company's President and CEO Denis Kourakin added that NGX's platform makes completion of sequencing projects simpler and more affordable, and allows customers to scale up their sequencing projects without the need for capital investment.